cannabinoid-derived inhalation capsule PPP011

{
  "id": "MLC-T-ONC-012225",
  "term": "cannabinoid-derived inhalation capsule PPP011",
  "field": "Oncology and biomedicine",
  "definition": "A capsule-based inhalation formulation containing a blend of synthetic cannabinoids, including cannabidiol (CBD) and tetrahydrocannabinol (THC), with potential anti-cachexia and analgesic activities. Upon inhalation of PPP011, the CBDs target and bind to the cannabinoid (CB) receptors. This may increase appetite, food intake and may relief pain. CB receptors, belonging to the G protein-coupled receptor superfamily, are involved in the regulation of appetite, food intake, body weight and nociception.",
  "synonyms": [
    "synthetic CBD PPP011"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/cannabinoid-derived-inhalation-capsule-ppp011/"
}